Neurobehavioral Assessment Platforms Market Forecasts to 2034 – Global Analysis By Solution Type (Neuropsychological Assessment Software, Digital Cognitive Assessment Platforms, Behavioral Assessment Solutions, Remote Neuroassessment Platforms, AI-Based Diagnostic Platforms and Neurobehavioral Screening Tools), Technology, Assessment Type, End User and By Geography
According to Stratistics MRC, the Global Neurobehavioral Assessment Platforms Market is accounted for $1.4 billion in 2026 and is expected to reach $5.4 billion by 2034 growing at a CAGR of 18.3% during the forecast period. Neurobehavioral assessment platforms refer to integrated digital systems designed to evaluate, measure, and monitor cognitive, emotional, and behavioral functions through standardized testing protocols and real-time data analysis. These platforms incorporate neuropsychological test batteries, speech and language analytics, wearable sensor integration, and artificial intelligence-driven diagnostic algorithms to identify neurological and psychiatric conditions. The technology enables clinicians, researchers, and educators to objectively quantify brain function across domains, including memory, attention, executive function, and emotional regulation for diagnostic and treatment planning purposes.
Market Dynamics:
Driver:
Growing neurological burden
The increasing prevalence of neurological disorders, traumatic brain injuries, and developmental conditions is driving demand for comprehensive neurobehavioral assessment platforms. Healthcare systems require efficient screening tools to identify cognitive impairment in aging populations. Educational institutions seek objective measures for learning disability identification and intervention planning. Forensic and legal applications require validated behavioral assessment documentation. These diverse end-user requirements create multiple revenue streams and market stability across clinical, academic, and commercial segments.
Restraint:
Specialized expertise required
The complexity of neurobehavioral assessment interpretation and the need for specialized training limit widespread adoption among general healthcare practitioners. Platform costs and required infrastructure investments create barriers for smaller clinics and developing market healthcare systems. Regulatory requirements for diagnostic software vary significantly across jurisdictions, complicating international expansion. These factors concentrate market penetration among specialized neurological centers and academic institutions with sufficient resources and expertise.
Opportunity:
Digital biomarker integration
The integration of digital biomarkers and continuous monitoring capabilities presents transformative opportunities for neurobehavioral assessment platform providers. Wearable devices and smartphone sensors enable passive data collection that supplements traditional active testing paradigms. Pharmaceutical companies seek objective endpoints for central nervous system drug trials. These expanded applications create new revenue models beyond one-time assessments toward longitudinal monitoring subscriptions that demonstrate ongoing clinical value and improve patient management.
Threat:
Unvalidated screening tools
The proliferation of unvalidated online cognitive tests and mental health screening tools threatens market differentiation for clinically rigorous neurobehavioral assessment platforms. Consumer-direct marketing of simplified brain health assessments dilutes professional confidence in digital evaluation methods. Regulatory ambiguity regarding software-based diagnostic claims creates competitive disadvantages for compliant manufacturers. These market dynamics pressure established providers to continuously demonstrate superior validity and reliability against lower-cost alternatives.
Covid-19 Impact:
The COVID-19 pandemic disrupted traditional in-person neuropsychological testing while accelerating development and adoption of remote assessment platforms. Healthcare providers required digital alternatives to maintain diagnostic services during lockdown periods. Post-pandemic, hybrid assessment models combining remote screening with targeted in-person validation have become standard practice. The crisis also heightened awareness of neurological sequelae from viral infection, increasing demand for post-COVID cognitive evaluation services.
The neuropsychological assessment software segment is expected to be the largest during the forecast period
The neuropsychological assessment software segment is expected to account for the largest market share during the forecast period, due to its established clinical validity and integration into standard diagnostic protocols for neurological and psychiatric conditions. These software platforms deliver computerized versions of validated test batteries that improve scoring accuracy and efficiency compared to paper-based methods. Healthcare systems value the regulatory compliance and normative data backing of established neuropsychological instruments. Reimbursement recognition supports sustained adoption.
The artificial intelligence segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the artificial intelligence segment is predicted to witness the highest growth rate, driven by its capacity to automate complex diagnostic pattern recognition and reduce assessment interpretation time for clinicians. Machine learning models trained on large neurobehavioral datasets identify subtle cognitive signatures associated with early-stage dementia and other neurological conditions. Natural language processing enables automated analysis of patient speech patterns for diagnostic insights. These capabilities significantly expand assessment accessibility beyond specialist centers.
Region with largest share:
During the forecast period, the North America region is expected to hold the largest market share, due to advanced neurological research infrastructure and established clinical guidelines that incorporate digital assessment tools. The United States leads with substantial academic research output validating neurobehavioral assessment technologies and favorable FDA regulatory pathways for diagnostic software. Major healthcare systems integrate platform-based cognitive screening into routine care protocols. Venture capital investment supports continuous innovation among domestic technology developers.
Region with highest CAGR:
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, due to expanding healthcare digitization initiatives and increasing recognition of neurological disorders as public health priorities. China and India invest heavily in medical technology infrastructure to address large patient populations. Japan's aging demographic drives demand for efficient cognitive screening tools. Government programs that support mental health awareness and early intervention create favorable policy environments for the adoption of neurobehavioral assessment platforms.
Key players in the market
Some of the key players in Neurobehavioral Assessment Platforms Market include Cambridge Cognition Holdings plc, Cogstate Ltd., Pearson plc, CNS Vital Signs, Creyos Corporation, EMOTIV Inc., Natus Medical Incorporated, Compumedics Limited, Philips Healthcare, Siemens Healthineers AG, GE HealthCare, Canon Medical Systems Corporation, FUJIFILM Healthcare, BrainCo Inc., Neuroelectrics, Brain Scientific Inc. and Kernel Inc..
Key Developments:
In June 2026, Cambridge Cognition Holdings plc launched an integrated neurobehavioral assessment platform that combines computerized cognitive testing with AI-driven behavioral analytics for comprehensive evaluation of brain function in clinical settings.
In May 2026, Cogstate Ltd. expanded its digital cognitive assessment portfolio to include real-time speech and language analytics for detecting early neurodegenerative changes in aging patient populations.
In April 2026, Pearson plc introduced a cloud-based neurobehavioral screening system designed for educational institutions to identify students requiring cognitive and emotional support interventions.
Solution Types Covered:
All the customers of this report will be entitled to receive one of the following free customization options:
Market Dynamics:
Driver:
Growing neurological burden
The increasing prevalence of neurological disorders, traumatic brain injuries, and developmental conditions is driving demand for comprehensive neurobehavioral assessment platforms. Healthcare systems require efficient screening tools to identify cognitive impairment in aging populations. Educational institutions seek objective measures for learning disability identification and intervention planning. Forensic and legal applications require validated behavioral assessment documentation. These diverse end-user requirements create multiple revenue streams and market stability across clinical, academic, and commercial segments.
Restraint:
Specialized expertise required
The complexity of neurobehavioral assessment interpretation and the need for specialized training limit widespread adoption among general healthcare practitioners. Platform costs and required infrastructure investments create barriers for smaller clinics and developing market healthcare systems. Regulatory requirements for diagnostic software vary significantly across jurisdictions, complicating international expansion. These factors concentrate market penetration among specialized neurological centers and academic institutions with sufficient resources and expertise.
Opportunity:
Digital biomarker integration
The integration of digital biomarkers and continuous monitoring capabilities presents transformative opportunities for neurobehavioral assessment platform providers. Wearable devices and smartphone sensors enable passive data collection that supplements traditional active testing paradigms. Pharmaceutical companies seek objective endpoints for central nervous system drug trials. These expanded applications create new revenue models beyond one-time assessments toward longitudinal monitoring subscriptions that demonstrate ongoing clinical value and improve patient management.
Threat:
Unvalidated screening tools
The proliferation of unvalidated online cognitive tests and mental health screening tools threatens market differentiation for clinically rigorous neurobehavioral assessment platforms. Consumer-direct marketing of simplified brain health assessments dilutes professional confidence in digital evaluation methods. Regulatory ambiguity regarding software-based diagnostic claims creates competitive disadvantages for compliant manufacturers. These market dynamics pressure established providers to continuously demonstrate superior validity and reliability against lower-cost alternatives.
Covid-19 Impact:
The COVID-19 pandemic disrupted traditional in-person neuropsychological testing while accelerating development and adoption of remote assessment platforms. Healthcare providers required digital alternatives to maintain diagnostic services during lockdown periods. Post-pandemic, hybrid assessment models combining remote screening with targeted in-person validation have become standard practice. The crisis also heightened awareness of neurological sequelae from viral infection, increasing demand for post-COVID cognitive evaluation services.
The neuropsychological assessment software segment is expected to be the largest during the forecast period
The neuropsychological assessment software segment is expected to account for the largest market share during the forecast period, due to its established clinical validity and integration into standard diagnostic protocols for neurological and psychiatric conditions. These software platforms deliver computerized versions of validated test batteries that improve scoring accuracy and efficiency compared to paper-based methods. Healthcare systems value the regulatory compliance and normative data backing of established neuropsychological instruments. Reimbursement recognition supports sustained adoption.
The artificial intelligence segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the artificial intelligence segment is predicted to witness the highest growth rate, driven by its capacity to automate complex diagnostic pattern recognition and reduce assessment interpretation time for clinicians. Machine learning models trained on large neurobehavioral datasets identify subtle cognitive signatures associated with early-stage dementia and other neurological conditions. Natural language processing enables automated analysis of patient speech patterns for diagnostic insights. These capabilities significantly expand assessment accessibility beyond specialist centers.
Region with largest share:
During the forecast period, the North America region is expected to hold the largest market share, due to advanced neurological research infrastructure and established clinical guidelines that incorporate digital assessment tools. The United States leads with substantial academic research output validating neurobehavioral assessment technologies and favorable FDA regulatory pathways for diagnostic software. Major healthcare systems integrate platform-based cognitive screening into routine care protocols. Venture capital investment supports continuous innovation among domestic technology developers.
Region with highest CAGR:
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, due to expanding healthcare digitization initiatives and increasing recognition of neurological disorders as public health priorities. China and India invest heavily in medical technology infrastructure to address large patient populations. Japan's aging demographic drives demand for efficient cognitive screening tools. Government programs that support mental health awareness and early intervention create favorable policy environments for the adoption of neurobehavioral assessment platforms.
Key players in the market
Some of the key players in Neurobehavioral Assessment Platforms Market include Cambridge Cognition Holdings plc, Cogstate Ltd., Pearson plc, CNS Vital Signs, Creyos Corporation, EMOTIV Inc., Natus Medical Incorporated, Compumedics Limited, Philips Healthcare, Siemens Healthineers AG, GE HealthCare, Canon Medical Systems Corporation, FUJIFILM Healthcare, BrainCo Inc., Neuroelectrics, Brain Scientific Inc. and Kernel Inc..
Key Developments:
In June 2026, Cambridge Cognition Holdings plc launched an integrated neurobehavioral assessment platform that combines computerized cognitive testing with AI-driven behavioral analytics for comprehensive evaluation of brain function in clinical settings.
In May 2026, Cogstate Ltd. expanded its digital cognitive assessment portfolio to include real-time speech and language analytics for detecting early neurodegenerative changes in aging patient populations.
In April 2026, Pearson plc introduced a cloud-based neurobehavioral screening system designed for educational institutions to identify students requiring cognitive and emotional support interventions.
Solution Types Covered:
- Neuropsychological Assessment Software
- Digital Cognitive Assessment Platforms
- Behavioral Assessment Solutions
- Remote Neuroassessment Platforms
- AI-Based Diagnostic Platforms
- Neurobehavioral Screening Tools
- Artificial Intelligence
- Machine Learning
- Cloud-Based Platforms
- Big Data Analytics
- Speech & Language Analytics
- Wearable Sensor Integration
- Digital Biomarker Analytics
- Cognitive Assessment
- Behavioral Assessment
- Memory Assessment
- Attention Assessment
- Executive Function Assessment
- Emotional & Psychological Assessment
- Comprehensive Neurobehavioral Assessment
- Hospitals
- Neurology Clinics
- Psychiatric Centers
- Academic & Research Institutes
- Rehabilitation Centers
- Diagnostic Laboratories
- Other End Users
- North America
- United States
- Canada
- Mexico
- Europe
- United Kingdom
- Germany
- France
- Italy
- Spain
- Netherlands
- Belgium
- Sweden
- Switzerland
- Poland
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Vietnam
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Colombia
- Chile
- Peru
- Rest of South America
- Rest of the World (RoW)
- Middle East
- Saudi Arabia
- United Arab Emirates
- Qatar
- Israel
- Rest of Middle East
- Africa
- South Africa
- Egypt
- Morocco
- Rest of Africa
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
All the customers of this report will be entitled to receive one of the following free customization options:
- Company Profiling
- Comprehensive profiling of additional market players (up to 3)
- SWOT Analysis of key players (up to 3)
- Regional Segmentation
- Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
- Competitive Benchmarking
1 EXECUTIVE SUMMARY
1.1 Market Snapshot and Key Highlights
1.2 Growth Drivers, Challenges, and Opportunities
1.3 Competitive Landscape Overview
1.4 Strategic Insights and Recommendations
2 RESEARCH FRAMEWORK
2.1 Study Objectives and Scope
2.2 Stakeholder Analysis
2.3 Research Assumptions and Limitations
2.4 Research Methodology
2.4.1 Data Collection (Primary and Secondary)
2.4.2 Data Modeling and Estimation Techniques
2.4.3 Data Validation and Triangulation
2.4.4 Analytical and Forecasting Approach
3 MARKET DYNAMICS AND TREND ANALYSIS
3.1 Market Definition and Structure
3.2 Key Market Drivers
3.3 Market Restraints and Challenges
3.4 Growth Opportunities and Investment Hotspots
3.5 Industry Threats and Risk Assessment
3.6 Technology and Innovation Landscape
3.7 Emerging and High-Growth Markets
3.8 Regulatory and Policy Environment
3.9 Impact of COVID-19 and Recovery Outlook
4 COMPETITIVE AND STRATEGIC ASSESSMENT
4.1 Porter's Five Forces Analysis
4.1.1 Supplier Bargaining Power
4.1.2 Buyer Bargaining Power
4.1.3 Threat of Substitutes
4.1.4 Threat of New Entrants
4.1.5 Competitive Rivalry
4.2 Market Share Analysis of Key Players
4.3 Product Benchmarking and Performance Comparison
5 GLOBAL NEUROBEHAVIORAL ASSESSMENT PLATFORMS MARKET, BY SOLUTION TYPE
5.1 Neuropsychological Assessment Software
5.2 Digital Cognitive Assessment Platforms
5.3 Behavioral Assessment Solutions
5.4 Remote Neuroassessment Platforms
5.5 AI-Based Diagnostic Platforms
5.6 Neurobehavioral Screening Tools
6 GLOBAL NEUROBEHAVIORAL ASSESSMENT PLATFORMS MARKET, BY TECHNOLOGY
6.1 Artificial Intelligence
6.2 Machine Learning
6.3 Cloud-Based Platforms
6.4 Big Data Analytics
6.5 Speech & Language Analytics
6.6 Wearable Sensor Integration
6.7 Digital Biomarker Analytics
7 GLOBAL NEUROBEHAVIORAL ASSESSMENT PLATFORMS MARKET, BY ASSESSMENT TYPE
7.1 Cognitive Assessment
7.2 Behavioral Assessment
7.3 Memory Assessment
7.4 Attention Assessment
7.5 Executive Function Assessment
7.6 Emotional & Psychological Assessment
7.7 Comprehensive Neurobehavioral Assessment
8 GLOBAL NEUROBEHAVIORAL ASSESSMENT PLATFORMS MARKET, BY END USER
8.1 Hospitals
8.2 Neurology Clinics
8.3 Psychiatric Centers
8.4 Academic & Research Institutes
8.5 Rehabilitation Centers
8.6 Diagnostic Laboratories
8.7 Other End Users
9 GLOBAL NEUROBEHAVIORAL ASSESSMENT PLATFORMS MARKET, BY GEOGRAPHY
9.1 North America
9.1.1 United States
9.1.2 Canada
9.1.3 Mexico
9.2 Europe
9.2.1 United Kingdom
9.2.2 Germany
9.2.3 France
9.2.4 Italy
9.2.5 Spain
9.2.6 Netherlands
9.2.7 Belgium
9.2.8 Sweden
9.2.9 Switzerland
9.2.10 Poland
9.2.11 Rest of Europe
9.3 Asia Pacific
9.3.1 China
9.3.2 Japan
9.3.3 India
9.3.4 South Korea
9.3.5 Australia
9.3.6 Indonesia
9.3.7 Thailand
9.3.8 Malaysia
9.3.9 Singapore
9.3.10 Vietnam
9.3.11 Rest of Asia Pacific
9.4 South America
9.4.1 Brazil
9.4.2 Argentina
9.4.3 Colombia
9.4.4 Chile
9.4.5 Peru
9.4.6 Rest of South America
9.5 Rest of the World (RoW)
9.5.1 Middle East
9.5.1.1 Saudi Arabia
9.5.1.2 United Arab Emirates
9.5.1.3 Qatar
9.5.1.4 Israel
9.5.1.5 Rest of Middle East
9.5.2 Africa
9.5.2.1 South Africa
9.5.2.2 Egypt
9.5.2.3 Morocco
9.5.2.4 Rest of Africa
10 STRATEGIC MARKET INTELLIGENCE
10.1 Industry Value Network and Supply Chain Assessment
10.2 White-Space and Opportunity Mapping
10.3 Product Evolution and Market Life Cycle Analysis
10.4 Channel, Distributor, and Go-to-Market Assessment
11 INDUSTRY DEVELOPMENTS AND STRATEGIC INITIATIVES
11.1 Mergers and Acquisitions
11.2 Partnerships, Alliances, and Joint Ventures
11.3 New Product Launches and Certifications
11.4 Capacity Expansion and Investments
11.5 Other Strategic Initiatives
12 COMPANY PROFILES
12.1 Cambridge Cognition Holdings plc
12.2 Cogstate Ltd.
12.3 Pearson plc
12.4 CNS Vital Signs
12.5 Creyos Corporation
12.6 EMOTIV Inc.
12.7 Natus Medical Incorporated
12.8 Compumedics Limited
12.9 Philips Healthcare
12.10 Siemens Healthineers AG
12.11 GE HealthCare
12.12 Canon Medical Systems Corporation
12.13 FUJIFILM Healthcare
12.14 BrainCo Inc.
12.15 Neuroelectrics
12.16 Brain Scientific Inc.
12.17 Kernel Inc.
1.1 Market Snapshot and Key Highlights
1.2 Growth Drivers, Challenges, and Opportunities
1.3 Competitive Landscape Overview
1.4 Strategic Insights and Recommendations
2 RESEARCH FRAMEWORK
2.1 Study Objectives and Scope
2.2 Stakeholder Analysis
2.3 Research Assumptions and Limitations
2.4 Research Methodology
2.4.1 Data Collection (Primary and Secondary)
2.4.2 Data Modeling and Estimation Techniques
2.4.3 Data Validation and Triangulation
2.4.4 Analytical and Forecasting Approach
3 MARKET DYNAMICS AND TREND ANALYSIS
3.1 Market Definition and Structure
3.2 Key Market Drivers
3.3 Market Restraints and Challenges
3.4 Growth Opportunities and Investment Hotspots
3.5 Industry Threats and Risk Assessment
3.6 Technology and Innovation Landscape
3.7 Emerging and High-Growth Markets
3.8 Regulatory and Policy Environment
3.9 Impact of COVID-19 and Recovery Outlook
4 COMPETITIVE AND STRATEGIC ASSESSMENT
4.1 Porter's Five Forces Analysis
4.1.1 Supplier Bargaining Power
4.1.2 Buyer Bargaining Power
4.1.3 Threat of Substitutes
4.1.4 Threat of New Entrants
4.1.5 Competitive Rivalry
4.2 Market Share Analysis of Key Players
4.3 Product Benchmarking and Performance Comparison
5 GLOBAL NEUROBEHAVIORAL ASSESSMENT PLATFORMS MARKET, BY SOLUTION TYPE
5.1 Neuropsychological Assessment Software
5.2 Digital Cognitive Assessment Platforms
5.3 Behavioral Assessment Solutions
5.4 Remote Neuroassessment Platforms
5.5 AI-Based Diagnostic Platforms
5.6 Neurobehavioral Screening Tools
6 GLOBAL NEUROBEHAVIORAL ASSESSMENT PLATFORMS MARKET, BY TECHNOLOGY
6.1 Artificial Intelligence
6.2 Machine Learning
6.3 Cloud-Based Platforms
6.4 Big Data Analytics
6.5 Speech & Language Analytics
6.6 Wearable Sensor Integration
6.7 Digital Biomarker Analytics
7 GLOBAL NEUROBEHAVIORAL ASSESSMENT PLATFORMS MARKET, BY ASSESSMENT TYPE
7.1 Cognitive Assessment
7.2 Behavioral Assessment
7.3 Memory Assessment
7.4 Attention Assessment
7.5 Executive Function Assessment
7.6 Emotional & Psychological Assessment
7.7 Comprehensive Neurobehavioral Assessment
8 GLOBAL NEUROBEHAVIORAL ASSESSMENT PLATFORMS MARKET, BY END USER
8.1 Hospitals
8.2 Neurology Clinics
8.3 Psychiatric Centers
8.4 Academic & Research Institutes
8.5 Rehabilitation Centers
8.6 Diagnostic Laboratories
8.7 Other End Users
9 GLOBAL NEUROBEHAVIORAL ASSESSMENT PLATFORMS MARKET, BY GEOGRAPHY
9.1 North America
9.1.1 United States
9.1.2 Canada
9.1.3 Mexico
9.2 Europe
9.2.1 United Kingdom
9.2.2 Germany
9.2.3 France
9.2.4 Italy
9.2.5 Spain
9.2.6 Netherlands
9.2.7 Belgium
9.2.8 Sweden
9.2.9 Switzerland
9.2.10 Poland
9.2.11 Rest of Europe
9.3 Asia Pacific
9.3.1 China
9.3.2 Japan
9.3.3 India
9.3.4 South Korea
9.3.5 Australia
9.3.6 Indonesia
9.3.7 Thailand
9.3.8 Malaysia
9.3.9 Singapore
9.3.10 Vietnam
9.3.11 Rest of Asia Pacific
9.4 South America
9.4.1 Brazil
9.4.2 Argentina
9.4.3 Colombia
9.4.4 Chile
9.4.5 Peru
9.4.6 Rest of South America
9.5 Rest of the World (RoW)
9.5.1 Middle East
9.5.1.1 Saudi Arabia
9.5.1.2 United Arab Emirates
9.5.1.3 Qatar
9.5.1.4 Israel
9.5.1.5 Rest of Middle East
9.5.2 Africa
9.5.2.1 South Africa
9.5.2.2 Egypt
9.5.2.3 Morocco
9.5.2.4 Rest of Africa
10 STRATEGIC MARKET INTELLIGENCE
10.1 Industry Value Network and Supply Chain Assessment
10.2 White-Space and Opportunity Mapping
10.3 Product Evolution and Market Life Cycle Analysis
10.4 Channel, Distributor, and Go-to-Market Assessment
11 INDUSTRY DEVELOPMENTS AND STRATEGIC INITIATIVES
11.1 Mergers and Acquisitions
11.2 Partnerships, Alliances, and Joint Ventures
11.3 New Product Launches and Certifications
11.4 Capacity Expansion and Investments
11.5 Other Strategic Initiatives
12 COMPANY PROFILES
12.1 Cambridge Cognition Holdings plc
12.2 Cogstate Ltd.
12.3 Pearson plc
12.4 CNS Vital Signs
12.5 Creyos Corporation
12.6 EMOTIV Inc.
12.7 Natus Medical Incorporated
12.8 Compumedics Limited
12.9 Philips Healthcare
12.10 Siemens Healthineers AG
12.11 GE HealthCare
12.12 Canon Medical Systems Corporation
12.13 FUJIFILM Healthcare
12.14 BrainCo Inc.
12.15 Neuroelectrics
12.16 Brain Scientific Inc.
12.17 Kernel Inc.
LIST OF TABLES
Table 1 Global Neurobehavioral Assessment Platforms Market Outlook, By Region (2023-2034) ($MN)
Table 2 Global Neurobehavioral Assessment Platforms Market Outlook, By Solution Type (2023-2034) ($MN)
Table 3 Global Neurobehavioral Assessment Platforms Market Outlook, By Neuropsychological Assessment Software (2023-2034) ($MN)
Table 4 Global Neurobehavioral Assessment Platforms Market Outlook, By Digital Cognitive Assessment Platforms (2023-2034) ($MN)
Table 5 Global Neurobehavioral Assessment Platforms Market Outlook, By Behavioral Assessment Solutions (2023-2034) ($MN)
Table 6 Global Neurobehavioral Assessment Platforms Market Outlook, By Remote Neuroassessment Platforms (2023-2034) ($MN)
Table 7 Global Neurobehavioral Assessment Platforms Market Outlook, By AI-Based Diagnostic Platforms (2023-2034) ($MN)
Table 8 Global Neurobehavioral Assessment Platforms Market Outlook, By Neurobehavioral Screening Tools (2023-2034) ($MN)
Table 9 Global Neurobehavioral Assessment Platforms Market Outlook, By Technology (2023-2034) ($MN)
Table 10 Global Neurobehavioral Assessment Platforms Market Outlook, By Artificial Intelligence (2023-2034) ($MN)
Table 11 Global Neurobehavioral Assessment Platforms Market Outlook, By Machine Learning (2023-2034) ($MN)
Table 12 Global Neurobehavioral Assessment Platforms Market Outlook, By Cloud-Based Platforms (2023-2034) ($MN)
Table 13 Global Neurobehavioral Assessment Platforms Market Outlook, By Big Data Analytics (2023-2034) ($MN)
Table 14 Global Neurobehavioral Assessment Platforms Market Outlook, By Speech & Language Analytics (2023-2034) ($MN)
Table 15 Global Neurobehavioral Assessment Platforms Market Outlook, By Wearable Sensor Integration (2023-2034) ($MN)
Table 16 Global Neurobehavioral Assessment Platforms Market Outlook, By Digital Biomarker Analytics (2023-2034) ($MN)
Table 17 Global Neurobehavioral Assessment Platforms Market Outlook, By Assessment Type (2023-2034) ($MN)
Table 18 Global Neurobehavioral Assessment Platforms Market Outlook, By Cognitive Assessment (2023-2034) ($MN)
Table 19 Global Neurobehavioral Assessment Platforms Market Outlook, By Behavioral Assessment (2023-2034) ($MN)
Table 20 Global Neurobehavioral Assessment Platforms Market Outlook, By Memory Assessment (2023-2034) ($MN)
Table 21 Global Neurobehavioral Assessment Platforms Market Outlook, By Attention Assessment (2023-2034) ($MN)
Table 22 Global Neurobehavioral Assessment Platforms Market Outlook, By Executive Function Assessment (2023-2034) ($MN)
Table 23 Global Neurobehavioral Assessment Platforms Market Outlook, By Emotional & Psychological Assessment (2023-2034) ($MN)
Table 24 Global Neurobehavioral Assessment Platforms Market Outlook, By Comprehensive Neurobehavioral Assessment (2023-2034) ($MN)
Table 25 Global Neurobehavioral Assessment Platforms Market Outlook, By End User (2023-2034) ($MN)
Table 26 Global Neurobehavioral Assessment Platforms Market Outlook, By Hospitals (2023-2034) ($MN)
Table 27 Global Neurobehavioral Assessment Platforms Market Outlook, By Neurology Clinics (2023-2034) ($MN)
Table 28 Global Neurobehavioral Assessment Platforms Market Outlook, By Psychiatric Centers (2023-2034) ($MN)
Table 29 Global Neurobehavioral Assessment Platforms Market Outlook, By Academic & Research Institutes (2023-2034) ($MN)
Table 30 Global Neurobehavioral Assessment Platforms Market Outlook, By Rehabilitation Centers (2023-2034) ($MN)
Table 31 Global Neurobehavioral Assessment Platforms Market Outlook, By Diagnostic Laboratories (2023-2034) ($MN)
Table 32 Global Neurobehavioral Assessment Platforms Market Outlook, By Other End Users (2023-2034) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.
Table 1 Global Neurobehavioral Assessment Platforms Market Outlook, By Region (2023-2034) ($MN)
Table 2 Global Neurobehavioral Assessment Platforms Market Outlook, By Solution Type (2023-2034) ($MN)
Table 3 Global Neurobehavioral Assessment Platforms Market Outlook, By Neuropsychological Assessment Software (2023-2034) ($MN)
Table 4 Global Neurobehavioral Assessment Platforms Market Outlook, By Digital Cognitive Assessment Platforms (2023-2034) ($MN)
Table 5 Global Neurobehavioral Assessment Platforms Market Outlook, By Behavioral Assessment Solutions (2023-2034) ($MN)
Table 6 Global Neurobehavioral Assessment Platforms Market Outlook, By Remote Neuroassessment Platforms (2023-2034) ($MN)
Table 7 Global Neurobehavioral Assessment Platforms Market Outlook, By AI-Based Diagnostic Platforms (2023-2034) ($MN)
Table 8 Global Neurobehavioral Assessment Platforms Market Outlook, By Neurobehavioral Screening Tools (2023-2034) ($MN)
Table 9 Global Neurobehavioral Assessment Platforms Market Outlook, By Technology (2023-2034) ($MN)
Table 10 Global Neurobehavioral Assessment Platforms Market Outlook, By Artificial Intelligence (2023-2034) ($MN)
Table 11 Global Neurobehavioral Assessment Platforms Market Outlook, By Machine Learning (2023-2034) ($MN)
Table 12 Global Neurobehavioral Assessment Platforms Market Outlook, By Cloud-Based Platforms (2023-2034) ($MN)
Table 13 Global Neurobehavioral Assessment Platforms Market Outlook, By Big Data Analytics (2023-2034) ($MN)
Table 14 Global Neurobehavioral Assessment Platforms Market Outlook, By Speech & Language Analytics (2023-2034) ($MN)
Table 15 Global Neurobehavioral Assessment Platforms Market Outlook, By Wearable Sensor Integration (2023-2034) ($MN)
Table 16 Global Neurobehavioral Assessment Platforms Market Outlook, By Digital Biomarker Analytics (2023-2034) ($MN)
Table 17 Global Neurobehavioral Assessment Platforms Market Outlook, By Assessment Type (2023-2034) ($MN)
Table 18 Global Neurobehavioral Assessment Platforms Market Outlook, By Cognitive Assessment (2023-2034) ($MN)
Table 19 Global Neurobehavioral Assessment Platforms Market Outlook, By Behavioral Assessment (2023-2034) ($MN)
Table 20 Global Neurobehavioral Assessment Platforms Market Outlook, By Memory Assessment (2023-2034) ($MN)
Table 21 Global Neurobehavioral Assessment Platforms Market Outlook, By Attention Assessment (2023-2034) ($MN)
Table 22 Global Neurobehavioral Assessment Platforms Market Outlook, By Executive Function Assessment (2023-2034) ($MN)
Table 23 Global Neurobehavioral Assessment Platforms Market Outlook, By Emotional & Psychological Assessment (2023-2034) ($MN)
Table 24 Global Neurobehavioral Assessment Platforms Market Outlook, By Comprehensive Neurobehavioral Assessment (2023-2034) ($MN)
Table 25 Global Neurobehavioral Assessment Platforms Market Outlook, By End User (2023-2034) ($MN)
Table 26 Global Neurobehavioral Assessment Platforms Market Outlook, By Hospitals (2023-2034) ($MN)
Table 27 Global Neurobehavioral Assessment Platforms Market Outlook, By Neurology Clinics (2023-2034) ($MN)
Table 28 Global Neurobehavioral Assessment Platforms Market Outlook, By Psychiatric Centers (2023-2034) ($MN)
Table 29 Global Neurobehavioral Assessment Platforms Market Outlook, By Academic & Research Institutes (2023-2034) ($MN)
Table 30 Global Neurobehavioral Assessment Platforms Market Outlook, By Rehabilitation Centers (2023-2034) ($MN)
Table 31 Global Neurobehavioral Assessment Platforms Market Outlook, By Diagnostic Laboratories (2023-2034) ($MN)
Table 32 Global Neurobehavioral Assessment Platforms Market Outlook, By Other End Users (2023-2034) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.
